News and Announcements
Craig Farrow Joins Bulletproof Board
- Published August 24, 2016 2:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
24th August 2016, ASX Announcement
Bulletproof Group Limited (ASX:BPF) welcomes Craig Farrow to the board as a non-executive director, effective today. Mr. Farrow has also accepted the role as chair of the Audit and Risk Committee.
Mr. Farrow is a Fellow of Chartered Accountants Australia New Zealand (CAANZ), Australian Institute of Company Directors (AICD) and Australian Institute of Management (AIM), whilst also a certified participating manager and holds a Diploma of Financial Services. A founding Partner of Brentnalls SA, he is now Chairman and continues as a partner of that firm.
Mr. Farrow is currently the deputy chairman of Vocus Communications, following its merger with M2 Group, where he held the Chairman role since 2006, having been part of the founding team of M2 in 1999. He is also a director of a number of private and unlisted public companies in the agribusiness, technology and professional services sectors.
To read the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
